Our previous research indicated that indoxyl sulfate, an indole derivative that accumulates in the blood during the progression of chronic kidney disease, contributes to CRC exacerbation via the activation of AhR, which is recognized as its receptor [68]. Here, AHR is linked to colorectal carcinoma.